{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "6158933",
  "DateCompleted": {
    "Year": "1980",
    "Month": "12",
    "Day": "18"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "08",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0304-8608",
      "JournalIssue": {
        "Volume": "65",
        "Issue": "2",
        "PubDate": {
          "Year": "1980"
        }
      },
      "Title": "Archives of virology",
      "ISOAbbreviation": "Arch Virol"
    },
    "ArticleTitle": "Failure of human fibroblast interferon to protect against rhinovirus infection.",
    "Pagination": {
      "StartPage": "135",
      "EndPage": "139",
      "MedlinePgn": "135-9"
    },
    "Abstract": {
      "AbstractText": [
        "Volunteers were treated with fibroblast interferon or placebo nose drops for four days. On the second day, they received a challenge with rhinovirus type 4. There was no difference in the clinical symptoms or viral shedding between the two groups. The possible reasons for this result are discussed."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Scott",
        "ForeName": "G M",
        "Initials": "GM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Reed",
        "ForeName": "S",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Cartwright",
        "ForeName": "T",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Tyrrell",
        "ForeName": "D",
        "Initials": "D"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial",
      "Controlled Clinical Trial",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Austria",
    "MedlineTA": "Arch Virol",
    "NlmUniqueID": "7506870",
    "ISSNLinking": "0304-8608"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Placebos"
    },
    {
      "RegistryNumber": "9008-11-1",
      "NameOfSubstance": "Interferons"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Administration, Intranasal"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Clinical Trials as Topic"
    },
    {
      "QualifierName": [
        "prevention & control"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Fibroblasts"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "therapeutic use"
      ],
      "DescriptorName": "Interferons"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "microbiology"
      ],
      "DescriptorName": "Nasal Mucosa"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Placebos"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "Rhinovirus"
    }
  ]
}